Eurofins Scientific SE (HAM:ESF0) EBITDA: €1,534 Mil (TTM As of Dec. 2025)


HAM:ESF0 Eurofins Scientific SE HAM:ESF0
87 GF Score
Price €66.88
GF Value €66.73
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Eurofins Scientific SE EBITDA?

Eurofins Scientific SE HAM:ESF0 +2.80% 87 EBITDA is €1,534 Mil as of Dec. 2025. GuruFocus rates HAM:ESF0 with a GF Score™ of 87/100 and a GF Value™ of €66.73 (Fairly Valued). The stock has 6 warning signs investors should review.

Eurofins Scientific SE's EBITDA for the six months ended in Dec. 2025 was €760 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €1,534 Mil.

During the past 12 months, the average EBITDA Growth Rate of Eurofins Scientific SE was 9.80% per year. During the past 3 years, the average EBITDA Growth Rate was 0.90% per year. During the past 5 years, the average EBITDA Growth Rate was -0.20% per year. During the past 10 years, the average EBITDA Growth Rate was 16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Eurofins Scientific SE was 46.00% per year. The lowest was -6.20% per year. And the median was 25.90% per year.

Eurofins Scientific SE's EBITDA per Share for the six months ended in Dec. 2025 was €4.12. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2025 was €8.23.

During the past 12 months, the average EBITDA per Share Growth Rate of Eurofins Scientific SE was 14.60% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 3.10% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 0.80% per year. During the past 10 years, the average EBITDA per Share Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Eurofins Scientific SE was 41.60% per year. The lowest was -5.30% per year. And the median was 23.30% per year.

Eurofins Scientific SE  (HAM:ESF0) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Eurofins Scientific SE EBITDA Related Terms


Eurofins Scientific SE EBITDA Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE EBITDA Chart

Eurofins Scientific SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,694.20 1,494.50 1,217.00 1,396.80 1,534.10

Eurofins Scientific SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 627.80 706.40 690.40 773.90 760.20

HAM:ESF0 vs TMO, DHR, IDXX: EBITDA Comparison

For the Diagnostics & Research subindustry, Eurofins Scientific SE's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE EV-to-EBITDA vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's EV-to-EBITDA falls into.


HAM:ESF0
87GF Score
Eurofins Scientific SE HAM:ESF0
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Eurofins Scientific SE's EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Eurofins Scientific SE's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2025, Eurofins Scientific SE's EBITDA was €1,534 Mil.

Eurofins Scientific SE's EBITDA for the quarter that ended in Dec. 2025 is calculated as

Eurofins Scientific SE's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2025, Eurofins Scientific SE's EBITDA was €760 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1,534 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of €1,534 Mil mean?
Eurofins Scientific SE (HAM:ESF0) has a EBITDA of €1,534 Mil as of Dec. 2025. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Eurofins Scientific SE.
Is Eurofins Scientific SE's EBITDA too high?
Eurofins Scientific SE's current EBITDA is €1,534 Mil. Overall, Eurofins Scientific SE has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's EBITDA compare to TMO and DHR?
Eurofins Scientific SE's EBITDA of €1,534 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Medical Diagnostics & Research company?
A good EBITDA depends on the Medical Diagnostics & Research industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Eurofins Scientific SE. Eurofins Scientific SE's current EBITDA is €1,534 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (HAM:ESF0) is currently considered Fairly Valued. The stock's GF Value™ is €66.73, compared to a current price of €66.88 — trading 0.2% above its estimated fair value. The current EBITDA is €1,534 Mil. Eurofins Scientific SE's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Eurofins Scientific SE (HAM:ESF0), the current EBITDA is €1,534 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (HAM:ESF0) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued. The current stock price of €66.88 is trading 0.2% above its estimated GF Value™ of €66.73. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for HAM:ESF0:

  • EBITDA: €1,534 Mil
  • GF Value™: €66.73 vs. price of €66.88 (0.2% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the HAM:ESF0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
87GF Score

Get the complete analysis for HAM:ESF0

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€66.88
Price
€66.73
GF Value